Evidence map›Paper›PMID 27539857›Full record

ArticleThe Journal of biological chemistry2016

A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity.

Yu-Chia Chen, Svetlana Semenova, Stanislav Rozov, Maria Sundvik, Joshua L Bonkowsky, Pertti Panula

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Does EGFR Signaling Mediate Orexin System Activity in Sleep Initiation?International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cerebral Dopamine Neurotrophic Factor Regulates Multiple Neuronal Subtypes and Behavior.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Yu-Chia ChenFrom the Neuroscience Center and Department of Anatomy, University of Helsinki, 00290 Helsinki, Finland and.
Svetlana SemenovaFrom the Neuroscience Center and Department of Anatomy, University of Helsinki, 00290 Helsinki, Finland and.
Stanislav RozovFrom the Neuroscience Center and Department of Anatomy, University of Helsinki, 00290 Helsinki, Finland and.
Maria SundvikFrom the Neuroscience Center and Department of Anatomy, University of Helsinki, 00290 Helsinki, Finland and.
Joshua L Bonkowskythe Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84113.
Pertti PanulaFrom the Neuroscience Center and Department of Anatomy, University of Helsinki, 00290 Helsinki, Finland and pertti.panula@helsinki.fi.
Center for Neurosciences · USUniversity of Helsinki · FIUniversity of Utah · US

Funding

Trans-Cellular Activation of Transcription to Analyze Dopaminergic Axon ReorganizDP2MH100008 · NIMH · UNIVERSITY OF UTAH · PI BONKOWSKY, JOSH LEITCH · 2012 to 2012
$2.2M
NIMH NIH HHS DP2 MH100008
6 · The paper itself

Abstract

Hypothalamic neurons expressing histamine and orexin/hypocretin (hcrt) are necessary for normal regulation of wakefulness. In Parkinson's disease, the loss of dopaminergic neurons is associated with elevated histamine levels and disrupted sleep/wake cycles, but the mechanism is not understood. To characterize the role of dopamine in the development of histamine neurons, we inhibited the translation of the two non-allelic forms of tyrosine hydroxylase (th1 and th2) in zebrafish larvae. We found that dopamine levels were reduced in both th1 and th2 knockdown, but the serotonin level and number of serotonin neurons remained unchanged. Further, we demonstrated that th2 knockdown increased histamine neuron number and histamine levels, whereas increased dopaminergic signaling using the dopamine precursor l-DOPA (l-3,4-dihydroxyphenylalanine) or dopamine receptor agonists reduced the number of histaminergic neurons. Increases in the number of histaminergic neurons were paralleled by matching increases in the numbers of hcrt neurons, supporting observations that histamine regulates hcrt neuron development. Finally, we show that histaminergic neurons surround th2-expressing neurons in the hypothalamus, and we suggest that dopamine regulates the terminal differentiation of histamine neurons via paracrine actions or direct synaptic neurotransmission. These results reveal a role for dopaminergic signaling in the regulation of neurotransmitter identity and a potential mechanism contributing to sleep disturbances in Parkinson's disease.

Indexed as

AnimalsDopaminergic NeuronsHistamineHypothalamusLevodopaNeurotransmitter AgentsOrexinsParkinson DiseaseSerotonergic NeuronsSleep Wake DisordersSynaptic TransmissionTyrosine 3-MonooxygenaseZebrafishZebrafish ProteinsHistamineLevodopaNeurotransmitter AgentsOrexinsth2 tyrosine hydroxylase 2, Danio rerioTyrosine 3-MonooxygenaseZebrafish Proteinsdopaminedopamine receptorhistaminehypothalamusmorpholinoorexinzebrafish

Identifiers

PMID27539857
PMCPMC5063973
OpenAlexW2514553841

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.